Veracyte IncNASDAQ:VCYT
- LAST PRICE33.7700
- TODAY'S CHANGE (%)0.2600 (0.7759%)
- Bid / Lots33.3100/ 1
- Ask / Lots34.2000/ 1
- Open / Previous Close34.0700 / 33.5100
- Day Range
- 52 Week Range
- Volume1,542,199
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VCYT |
|---|---|---|
| 09:32 ET | 5685 | 34 |
| 09:34 ET | 2431 | 34.349 |
| 09:36 ET | 1745 | 34.4 |
| 09:38 ET | 3549 | 34.46 |
| 09:39 ET | 6066 | 34.625 |
| 09:41 ET | 1371 | 34.615 |
| 09:43 ET | 100 | 34.695 |
| 09:45 ET | 227 | 34.595 |
| 09:48 ET | 300 | 34.57 |
| 09:50 ET | 4328 | 34.6797 |
| 09:52 ET | 1200 | 34.5 |
| 09:54 ET | 1200 | 34.275 |
| 09:56 ET | 900 | 34.35 |
| 09:57 ET | 400 | 34.325 |
| 09:59 ET | 1200 | 34.32 |
| 10:01 ET | 2668 | 34.48 |
| 10:03 ET | 3240 | 34.59 |
| 10:06 ET | 21187 | 34.56 |
| 10:08 ET | 872 | 34.44 |
| 10:10 ET | 400 | 34.43 |
| 10:12 ET | 1306 | 34.49 |
| 10:14 ET | 2721 | 34.53 |
| 10:15 ET | 2339 | 34.5 |
| 10:17 ET | 400 | 34.415 |
| 10:19 ET | 501 | 34.37 |
| 10:21 ET | 700 | 34.41 |
| 10:24 ET | 200 | 34.435 |
| 10:26 ET | 1621 | 34.445 |
| 10:28 ET | 1400 | 34.465 |
| 10:30 ET | 2521 | 34.33 |
| 10:32 ET | 400 | 34.28 |
| 10:33 ET | 1201 | 34.33 |
| 10:35 ET | 100 | 34.38 |
| 10:37 ET | 500 | 34.4 |
| 10:39 ET | 300 | 34.5 |
| 10:42 ET | 700 | 34.5 |
| 10:44 ET | 900 | 34.5 |
| 10:46 ET | 700 | 34.55 |
| 10:48 ET | 1350 | 34.625 |
| 10:50 ET | 900 | 34.67 |
| 10:51 ET | 588 | 34.6751 |
| 10:53 ET | 1713 | 34.5614 |
| 10:55 ET | 500 | 34.63 |
| 10:57 ET | 1100 | 34.51 |
| 11:00 ET | 1200 | 34.565 |
| 11:02 ET | 100 | 34.59 |
| 11:04 ET | 200 | 34.58 |
| 11:06 ET | 1564 | 34.595 |
| 11:09 ET | 1539 | 34.47 |
| 11:11 ET | 1214 | 34.465 |
| 11:13 ET | 400 | 34.42 |
| 11:15 ET | 600 | 34.49 |
| 11:20 ET | 400 | 34.51 |
| 11:22 ET | 100 | 34.43 |
| 11:24 ET | 701 | 34.45 |
| 11:26 ET | 476723 | 34.57 |
| 11:27 ET | 1600 | 34.5 |
| 11:29 ET | 6000 | 34.61 |
| 11:31 ET | 8105 | 34.6 |
| 11:33 ET | 11132 | 34.71 |
| 11:36 ET | 2775 | 34.825 |
| 11:38 ET | 360 | 34.7 |
| 11:40 ET | 1572 | 34.555 |
| 11:42 ET | 200 | 34.5 |
| 11:44 ET | 600 | 34.64 |
| 11:45 ET | 2403 | 34.7 |
| 11:47 ET | 200 | 34.61 |
| 11:49 ET | 5306 | 34.585 |
| 11:51 ET | 1200 | 34.625 |
| 11:54 ET | 1308 | 34.74 |
| 11:56 ET | 729 | 34.66 |
| 11:58 ET | 331 | 34.64 |
| 12:00 ET | 2900 | 34.53 |
| 12:02 ET | 753 | 34.485 |
| 12:03 ET | 800 | 34.46 |
| 12:05 ET | 2410 | 34.604 |
| 12:07 ET | 900 | 34.51 |
| 12:09 ET | 1513 | 34.58 |
| 12:12 ET | 100 | 34.555 |
| 12:14 ET | 300 | 34.56 |
| 12:16 ET | 1179 | 34.49 |
| 12:18 ET | 500 | 34.48 |
| 12:20 ET | 534 | 34.53 |
| 12:21 ET | 551 | 34.5 |
| 12:23 ET | 800 | 34.495 |
| 12:25 ET | 920 | 34.5 |
| 12:27 ET | 216 | 34.51 |
| 12:30 ET | 2522 | 34.48 |
| 12:32 ET | 2859 | 34.46 |
| 12:34 ET | 2944 | 34.49 |
| 12:36 ET | 2103 | 34.475 |
| 12:38 ET | 200 | 34.44 |
| 12:39 ET | 793 | 34.4 |
| 12:41 ET | 403 | 34.38 |
| 12:45 ET | 100 | 34.31 |
| 12:48 ET | 2091 | 34.3001 |
| 12:52 ET | 700 | 34.3 |
| 12:54 ET | 200 | 34.345 |
| 12:56 ET | 799 | 34.365 |
| 12:57 ET | 1662 | 34.3 |
| 01:01 ET | 400 | 34.3 |
| 01:03 ET | 200 | 34.3 |
| 01:06 ET | 300 | 34.305 |
| 01:08 ET | 1433 | 34.26 |
| 01:10 ET | 1300 | 34.11 |
| 01:12 ET | 2466 | 34.02 |
| 01:14 ET | 381 | 34.05 |
| 01:15 ET | 1500 | 34.015 |
| 01:17 ET | 806 | 34.02 |
| 01:19 ET | 2292 | 33.99 |
| 01:21 ET | 1000 | 34.035 |
| 01:24 ET | 200 | 34.0625 |
| 01:26 ET | 200 | 34.13 |
| 01:28 ET | 986 | 34.13 |
| 01:30 ET | 796 | 34.17 |
| 01:32 ET | 500 | 34.17 |
| 01:33 ET | 500 | 34.2 |
| 01:35 ET | 200 | 34.17 |
| 01:37 ET | 300 | 34.16 |
| 01:39 ET | 302 | 34.08 |
| 01:42 ET | 557 | 34.075 |
| 01:44 ET | 300 | 34.09 |
| 01:46 ET | 401 | 34.075 |
| 01:48 ET | 1827 | 34.13 |
| 01:50 ET | 1200 | 34.145 |
| 01:51 ET | 200 | 34.11 |
| 01:53 ET | 200 | 34.155 |
| 01:55 ET | 1326 | 34.29 |
| 01:57 ET | 2599 | 34.235 |
| 02:00 ET | 200 | 34.19 |
| 02:02 ET | 600 | 34.195 |
| 02:04 ET | 701 | 34.21 |
| 02:06 ET | 100 | 34.24 |
| 02:08 ET | 600 | 34.21 |
| 02:09 ET | 502 | 34.08 |
| 02:11 ET | 500 | 34.1 |
| 02:13 ET | 400 | 34.13 |
| 02:18 ET | 400 | 34.13 |
| 02:20 ET | 500 | 34.11 |
| 02:22 ET | 345 | 34.07 |
| 02:24 ET | 602 | 34.05 |
| 02:26 ET | 500 | 34.02 |
| 02:27 ET | 300 | 34 |
| 02:29 ET | 713 | 33.96 |
| 02:31 ET | 8293 | 33.7825 |
| 02:33 ET | 1603 | 33.81 |
| 02:36 ET | 708 | 33.8 |
| 02:38 ET | 500 | 33.77 |
| 02:40 ET | 500 | 33.77 |
| 02:42 ET | 900 | 33.83 |
| 02:44 ET | 400 | 33.9 |
| 02:45 ET | 500 | 33.9 |
| 02:47 ET | 300 | 33.92 |
| 02:49 ET | 300 | 33.91 |
| 02:51 ET | 1046 | 33.8948 |
| 02:54 ET | 200 | 33.9298 |
| 02:56 ET | 300 | 33.87 |
| 02:58 ET | 100 | 33.935 |
| 03:00 ET | 800 | 33.98 |
| 03:02 ET | 900 | 33.91 |
| 03:03 ET | 1300 | 33.85 |
| 03:05 ET | 200 | 33.855 |
| 03:07 ET | 385 | 33.82 |
| 03:09 ET | 13303 | 33.78 |
| 03:12 ET | 400 | 33.72 |
| 03:14 ET | 1200 | 33.76 |
| 03:16 ET | 200 | 33.76 |
| 03:18 ET | 700 | 33.77 |
| 03:20 ET | 900 | 33.78 |
| 03:21 ET | 964 | 33.76 |
| 03:23 ET | 732 | 33.735 |
| 03:25 ET | 200 | 33.72 |
| 03:27 ET | 2601 | 33.685 |
| 03:30 ET | 800 | 33.69 |
| 03:32 ET | 300 | 33.67 |
| 03:34 ET | 13573 | 33.7 |
| 03:36 ET | 675 | 33.61 |
| 03:38 ET | 1696 | 33.63 |
| 03:39 ET | 5727 | 33.6 |
| 03:41 ET | 1897 | 33.54 |
| 03:43 ET | 500 | 33.565 |
| 03:45 ET | 2629 | 33.52 |
| 03:48 ET | 300 | 33.535 |
| 03:50 ET | 6773 | 33.58 |
| 03:52 ET | 1295 | 33.58 |
| 03:54 ET | 3662 | 33.64 |
| 03:56 ET | 6595 | 33.59 |
| 03:57 ET | 6761 | 33.71 |
| 03:59 ET | 358267 | 33.77 |
Sep 15, 2024
Sep 4, 2024
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors, from 4:05PM ET on Wednesday Sep 04, 2024 by Dow Jones
4:05PM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 28, 2024
DJ Veracyte Is Maintained at Buy by Needham, from 5:39AM ET on Wednesday Aug 28, 2024 by Dow Jones
5:39AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Veracyte Inc | 2.6B | -45.4x | --- |
Genmab A/S | 15.8B | 19.3x | +22.71% |
Catalyst Pharmaceuticals Inc | 2.4B | 36.7x | --- |
Galapagos NV | 1.9B | 54.8x | --- |
Beam Therapeutics Inc | 2.1B | -14.2x | --- |
Amicus Therapeutics Inc | 3.2B | -27.0x | --- |
Company Information
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA labs in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.
Contact Information
- Headquarters
- 6000 Shoreline Court, Suite 300SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-243-6300
- Fax
- 650-243-6301
Executives
- Independent Chairman of the Board
- Robert Epstein
- Chief Executive Officer, Director
- Marc Stapley
- Chief Financial Officer
- Rebecca Chambers
- Chief Human Resource Officer, General Counsel
- Annie Mcguire
- Chief Scientific Officer, Chief Medical Officer
- Phillip Febbo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $399.6M |
Shares Outstanding | 76.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-0.74 |
Book Value | $14.25 |
P/E Ratio | -45.4x |
Price/Sales (TTM) | 6.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
